Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | 1,076,841 | reported | 07 Jun 2023 | tx 3+8,189−694,421 |
| Tracon Pharmaceuticals, Inc. | 76,048 | reported | 09 Dec 2019 | tx 2−384,130 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Jun 2023 | SALE | Bellerophon Therapeutics, Inc. | 134,421 | 0.83 USD | |
| 18 May 2023 | SALE | Bellerophon Therapeutics, Inc. | 560,000 | 9.46 USD | |
| 07 Jun 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 8,189 | 4.00 USD | |
| 09 Dec 2019 | SALE | Tracon Pharmaceuticals, Inc. | 340,134 | 2.92 USD | |
| 05 Dec 2019 | SALE | Tracon Pharmaceuticals, Inc. | 43,996 | 3.05 USD |